Abstract
Reproductive medicine encompasses much beyond the treatment of infertility. However, for the purpose of this article, we will focus primarily on the drugs in current use for the treatment of anovulatory infertility (where the aim of treatment is to achieve monofollicular development) and for in-vitro fertilisation (where multifollicular development in is the goal). Since the discovery and isolation of gonadotrophin (i.e. follicle-stimulating hormone, luteinising hormone and human chorionic gonadotrophin) and gonadotrophin-releasing hormone, an extensive variety of pharmacotherapeutic preparations have been developed. An overview of the different medications used in current practice is provided in this article. In addition to describing their mechanism of action, their clinical application and associated outcomes are also reviewed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
